Theranos investors have an opportunity to recover their investment losses.
Click "Join this Class Action" above.
Rosen Law Firm announces that it is investigating potential securities claims on behalf of investors of Theranos, Inc. resulting from allegations that Theranos may have issued materially misleading business information to investors.
If you invested in Theranos and would like to join the action, please click "Join This Class Action" above.
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Theranos, Inc.
New York, N.Y., March 8, 2016. Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of investors of Theranos, Inc. resulting from allegations that Theranos may have issued materially misleading business information to investors.
On October 16, 2015, The New York Times reported that Theranos “temporarily halted its trademark practice of collecting tiny blood samples from finger pricks” due to questions the FDA raised. On January 27, 2016, The Wall Street Journal reported that “Federal inspectors found ‘deficient practices’ at a Theranos, Inc. laboratory that ‘pose immediate jeopardy to patient health and safety.” On March 8, 2016, The Wall Street Journal reported that a “federal inspection report said a Theranos, Inc. laboratory ran an important blood test on 81 patients in a six-month period despite erratic results from quality-control checks meant to ensure the test’s accuracy,” and that “[i]naccurate results from the test can be especially serious for patients.”
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Theranos investors. If you invested in Theranos, please visit the firm’s website at http://rosenlegal.com/cases-854.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at email@example.com or firstname.lastname@example.org.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827